Pictet Asset Management
IMCR icon

Pictet Asset Management’s Immunocore IMCR Stock Holding History

Pictet Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-706,607
Closed -$45.9M – 2003
2024
Q1 		$45.9M Sell
706,607
-103,000
-13% -$7.07M 0.05% 325
2023
Q4 		$55.3M Sell
809,607
-100,631
-11% -$5.23M 0.06% 286
2023
Q3 		$47.2M Buy
+910,238
New +$53.9M 0.06% 296

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Pictet Asset Management's IMCR Position: Q2 2024 in Review

Pictet Asset Management sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 706,607 shares — an estimated $45.9M sold.

Pictet Asset Management first reported a position in IMCR in Q3 2023 and held it in 3 quarters. The position peaked at $55.3M in Q4 2023. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Pictet Asset Management reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Pictet Asset Management sold 706,607 Immunocore shares in Q2 2024, an estimated $45.9M.
  • Pictet Asset Management first reported a position in Immunocore in Q3 2023 and held it in 3 quarters.
  • Pictet Asset Management's Immunocore position peaked at $55.3M in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Pictet Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.